Editor-in-Chief: Alaa Abd-Elsayed, MD, PhD

Current Issue - June 2021 - Vol 5 Issue 4 Index  |  Previous  |  Next



  1. 2021;5;223-226 Spinal Cord Stimulator for Treating Chemotherapy-induced Peripheral Neuropathy
    Case Report
    Alaa Abd-Elsayed, MD, Michael Gyorfi, MD, and Meghan Hughes, MD.

BACKGROUND: Chemotherapy-induced peripheral neuropathy (CIPN) is not only one of the most common adverse experiences of cancer survivors, but it is also one which has the greatest effect on quality of life. Ultimately, CIPN can lead to unwanted modification of treatment such as chemotherapy dose reductions or termination of treatment altogether.

CASE REPORT: We present a case of a 47-year-old man with severe bilateral CIPN resistant to conservative management, who was successfully treated with spinal cord stimulation.

CONCLUSION: Spinal cord stimulation can be an effective treatment for CIPN resistant to conservative management.

KEY WORDS: Spinal cord stimulator, chemotherapy induced neuropathy, peripheral neuropathy